Schizophrenia/Psychosis News http://www.mdlinx.com/PsychLinx/news.cfm/newspage/1/spec_id/7/subspec_id/89 Schizophrenia/Psychosis en-us Copyright 2009 MDLinx, Inc. <![CDATA[Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled study]]> http://www.mdlinx.com/PsychLinx/xml-article.cfm/2973229 12/7/2009 Schizophrenia Research]]> http://www.mdlinx.com/PsychLinx/xml-article.cfm/2973229 <![CDATA[Comparing effectiveness of risperidone with first-generation antipsychotic medications in patients with schizophrenia-spectrum disorders]]> http://www.mdlinx.com/PsychLinx/xml-article.cfm/2973560 12/7/2009 Journal of Psychopharmacology]]> http://www.mdlinx.com/PsychLinx/xml-article.cfm/2973560 <![CDATA[The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: A double-blind randomized placebo-controlled trial]]> http://www.mdlinx.com/PsychLinx/xml-article.cfm/2973230 12/7/2009 Schizophrenia Research]]> http://www.mdlinx.com/PsychLinx/xml-article.cfm/2973230 <![CDATA[Setting standards for physical health monitoring in patients on antipsychotics]]> http://www.mdlinx.com/PsychLinx/xml-article.cfm/2972273 12/7/2009 Psychiatric Bulletin]]> http://www.mdlinx.com/PsychLinx/xml-article.cfm/2972273 <![CDATA[Psychotic Disorders and Repeat Offending: Systematic Review and Meta-analysis]]> http://www.mdlinx.com/PsychLinx/xml-article.cfm/2972947 12/7/2009 Schizophrenia Bulletin]]> http://www.mdlinx.com/PsychLinx/xml-article.cfm/2972947 <![CDATA[Brain Cannabinoid CB2 Receptor in Schizophrenia]]> http://www.mdlinx.com/PsychLinx/xml-article.cfm/2961235 12/7/2009 Biological Psychiatry]]> http://www.mdlinx.com/PsychLinx/xml-article.cfm/2961235